Skip to main content
. 2021 Sep 11;114(6):808–818. doi: 10.1093/jnci/djab171

Figure 3.

Figure 3.

Meta-analysis of differences in mean change in global quality of life from baseline to follow-up in patients treated with immune checkpoint inhibitors vs other regimens. Positive values favor immune checkpoint inhibitors. Random effect models were used with a 2-sided alpha level of.05. Error bars indicate the 95% confidence intervals (CI). IO = immune checkpoint inhibitor.